Opendata, web and dolomites

FRINGE SIGNED

Fluorescence and Reactive oxygen Intermediates by Neutron Generated electronic Excitation as a foundation for radically new cancer therapies

Total Cost €

0

EC-Contrib. €

0

Partnership

0

Views

0

 FRINGE project word cloud

Explore the words cloud of the FRINGE project. It provides you a very rough idea of what is the project "FRINGE" about.

oncologists    centres    generate    suffer    photochemists    scientific    energy    proof    immunogenic    hybrid    cancers    tuned    lay    reactive    gd    join    emission    cells    cell    treat    lying    therapeutic    disciplines    species    contain    concomitant    eliminate    theranostic    physicists    electron    tumour    agent    kill    vaccine    radio    synthetic    oxygen    mutagenic    breakthrough    interdisciplinary    deep    neutron    aggressive    chemical    blood    limited    mainly    occult    interaction    tumours    world    team    transfer    death    ambient    ps    magnetic    accumulate    beam    act    confirmed    advantages    survival    imaging    nuclear    combination    activated    specificity    incoming    combine    sufficient    penetration    gadolinium    foundations    agents    metastasis    fluorescence    insufficient    experts    tissue    compromised    excitation    cancer    neutrons    metal    rates    photosensitisers    externally    photomedical    fringe    contrast    preferentially    experimental    barrier    genuinely    heart    causing    renowned    curative    brain    lack    marginal    therapies    therapy    light    difficult    resonance    photobiologists    exactly    medical    modality    radiation    pss    chemists    forces    designed    quantum   

Project "FRINGE" data sheet

The following table provides information about the project.

Coordinator
OSLO UNIVERSITETSSYKEHUS HF 

Organization address
address: KIRKEVEIEN 166 TARNBYGGET
city: OSLO
postcode: 450
website: http://www.oslo-universitetssykehus.no

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Norway [NO]
 Total cost 3˙979˙485 €
 EC max contribution 3˙979˙485 € (100%)
 Programme 1. H2020-EU.1.2.1. (FET Open)
 Code Call H2020-FETOPEN-2018-2019-2020-01
 Funding Scheme RIA
 Starting year 2019
 Duration (year-month-day) from 2019-05-01   to  2023-10-31

 Partnership

Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    OSLO UNIVERSITETSSYKEHUS HF NO (OSLO) coordinator 898˙118.00
2    "NATIONAL CENTER FOR SCIENTIFIC RESEARCH ""DEMOKRITOS""" EL (AGIA PARASKEVI) participant 719˙687.00
3    INSTITUTT FOR ENERGITEKNIKK NO (KJELLER) participant 559˙875.00
4    SYNTHETICA AS NO (OSLO) participant 446˙875.00
5    UNIVERSITAT POLITECNICA DE VALENCIA ES (VALENCIA) participant 384˙375.00
6    VYSOKA SKOLA CHEMICKO-TECHNOLOGICKA V PRAZE CZ (PRAHA) participant 382˙500.00
7    UNIVERSITAT DE GIRONA ES (GIRONA) participant 336˙250.00
8    ACCELOPMENT AG CH (ZUERICH) participant 251˙803.00

Map

 Project objective

Deep lying tumours like aggressive brain cancer remain very difficult to treat and existing therapies offer only marginal increase in survival rates. In the case of photomedical therapies they are very effective, but mainly limited by their insufficient depth of light penetration into tissue. Current neutron-based therapies have sufficient penetration depth but suffer from lack of cancer specificity. In FRINGE we propose a genuinely new hybrid-technology. At its heart are chemical agents (photosensitisers - PS) which preferentially accumulate in the tumours especially in brain cancers where the blood brain barrier is compromised. The PSs designed for FRINGE will contain metal centres like Gadolinium (Gd), to enable interaction with incoming neutrons and facilitate the transfer of neutron energy into electron excitation of the PS, confirmed by concomitant fluorescence emission. Interaction with ambient oxygen will generate reactive oxygen species which will kill the tumour cells. The main scientific breakthrough of this project will be to establish experimental proof-of-principle of this novel neutron-activated therapy. FRINGE will combine the advantages of photomedical therapies (no mutagenic radiation) with the advantages of neutron-based therapies (large penetration depth). The externally-applied neutron beam can be energy-tuned to become therapeutic exactly at the depth of the tumour. Exploiting Gd as a contrast agent, FRINGE can also become a theranostic modality by use of magnetic resonance imaging. FRINGE has the potential of causing immunogenic cell death to cancers which could eliminate occult metastasis and act as a ‘cancer vaccine’. The highly interdisciplinary project team comprises world renowned experts from a unique combination of disciplines: Nuclear physicists, synthetic chemists, photochemists, photobiologists, medical physicists, quantum chemists and radio-oncologists will join forces to lay the foundations for a novel, curative cancer therapy.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "FRINGE" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email (fabio@fabiodisconzi.com) and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "FRINGE" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.1.2.1.)

PANACHE (2020)

Production of next generation modulators of pannexins and connexins as novel therapeutics in the treatment of inflammatory cardiovascular, hepatic and joint diseases.

Read More  

EggSorter (2019)

Device and method for automatized egg cell inspection and sorting

Read More  

CLASSY (2019)

Cell-Like ‘Molecular Assembly Lines’ of Programmable Reaction Sequences as Game-Changers in Chemical Synthesis

Read More